Parathyroid hormone (PTH) is rapidly degraded in vivo, with a half life of 5 min: it is also unstable in blood samples. ' We currently use the Ciba Corning Magiclite assay (Ciba Corning Diagnostics, Halstead, UK) for the measurement of intact PTH, and correct handling of the blood specimens is of paramount importance for accurate results. The manufacturers state that serum should be separated from the blood sample within 2 h and either analysed immediately or stored at 4°C for up to 8 h or at -20°C for a maximum of 4 months.! This means that samples, once taken, require rapid transportation to the laboratory for separation and storage of serum.
We have recently been asked to participate in a study involving the collection of PTH samples by general practitioners, and organization of such a study required knowledge of the stability of PTH in vitro. We therefore undertook a pilot study to determine the stability of PTH in whole blood samples and serum at room temperature (RT) and 4°C.
Blood samples (four from each patient, in serum separator tubes, without anticoagulant) were obtained from 18 in-patients with either suspected hyperparathyroidism (n = 12) or in renal failure (n = 6). The latter were known to have high serum PTH concentrations. Samples were allowed to clot for 2 h at RT after collection, in accordance with the manufacturer's guidelines.? Two of the tubes were centrifuged, and an aliquot of serum was taken from one tube and immediately frozen at -20°C; this served as a reference sample for each patient ('zero time' value). One tube was then stored at RT, the other at 4°C until analysis.
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The two remaining tubes were not centrifuged; one was stored at RT, the other at 4°C. Serum samples were removed from these tubes immediately prior to analysis.
The patients were divided into two groups according to the time lapsed between taking the sample and starting the assay. Samples from 11 patients (eight non-renal and three renal) were analysed within 2-6 h at a mean time of 4·9 h (group A), whilst the remaining seven were analysed within 24-30 h at a mean time of 26' 4 h (group B).
For each patient, each sample type was analysed in quintuplicate and a mean value was calculated. For each group, data obtained from each sample type (i.e. serum or whole blood at RT or at 4°C) was then pooled and expressed as a mean percentage of the zero time value (the latter being assigned a value of 100070). Comparison with the zero time levels was by paired t-test in all cases. Serum PTH concentrations for the 18 patients ranged from 1. 9 to 23· 7 pmol/L.
In group A (samples kept for up to 6 h) there was no significant difference (P> O' 05) between PTH values at zero time and those for specimens stored at RT and at 4°C. This was true both for whole blood [RT: 99·9% (SD 13,6%) of zero time value; 4°C: 106·3% (SD 11,7%) of zero time value) and for serum [RT: 101·1 % (SD 14'3%) of zero time value; 4°C: 104·7% (SD 10· 1%) of zero time value) . Samples kept for the full 6 h prior to analysis did not show greater deterioration of PTH than those analysed at shorter times.
In group B (samples kept for 24-30 h) there was a significant decrease (P<O·OI) in PTH concentration in samples stored at RT, both for whole blood and serum. Thus, PTH in whole blood specimens fell to a mean value of 74·5% (SD 17,2%) of the zero time value, while the serum samples decreased to a mean value of 69'6% (SD 19'5%). However, group B samples stored at 4°C for 24-30 h showed no significantdifference (P>0·05) from the PTH concentration at zero time (Fig. 1) . Whole blood samples had mean PTH values of 103. 61170 (SD 8·2%) of the zero time value over the concentration range 3· 1-28' 9 pmol/L. For serum samples, the mean concentration at 24-30 h was 100' 31170 (SD 7· 1%) of the zero time value. removing the need for rapid transport to the laboratory on ice. Newman and Ashby! previously investigated the stability of PTH at both room temperature and at 4°C, in a group of eight patients. They found that storing whole blood and serum samples for 18 h at RT induced a significant reduction in measured PTH levels, in accordance with our findings. However, these workers also reported that serum samples kept at 4°C for 18 h also showed significant deterioration with a mean decrease in value of 10%. The contrasting fmdings may reflect differing antibody specificities. Thus, Newman and Ashby used the Allegro intact PTH assay (Nichols Institute, San Juan Capistrano, CA, USA) which utilizes polyclonal PTH antibodies. This assay may, therefore, detect both intact PTH and PTH fragments. The Ciba Corning Magiclite assay described here, however, uses sheep anti-human polyclonal antibodies to the residues 1-34 of PTH (N terminal) and a mouse monoclonal antibody to residues 44-68. The manufacturers state there is no cross reactivity with PTH fragments.f This suggests that stability studies may not be transferable across using different assay systems.
